M Ranson

Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

Stuart C. White, Paul Lorigan, Geoffrey P. Margison et al. · British Journal of Cancer · 2006 · 149 citations · Full text

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer

Omar Khan, M Ranson, Michalis Michael et al. · British Journal of Cancer · 2008 · 62 citations · Full text

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study

DC Betticher, Heather Anderson, M Ranson et al. · British Journal of Cancer · 1995 · 56 citations · Full text

Non-small-cell Lung Cancer, Medicine, Pharmacology +8

Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer

Jeremy Braybrooke, M Ranson, C. Manegold et al. · Lung Cancer · 2003 · 22 citations

Medicine, Exatecan Mesylate, Pathology +8

Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer.

Nicholas Thatcher, Gordon C. Jayson, Brian Bradley et al. · PubMed · 1997 · 19 citations